Previous Page  9 / 9
Information
Show Menu
Previous Page 9 / 9
Page Background

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

May 24-25, 2018

London, UK

Vascular Surgery 2018

Page 57

3

rd

Edition of World Congress & Exhibition on

Vascular Surgery

The role of neutrophils in abdominal aortic

aneurysms

Christoph Neumayer

Medical University Vienna, Austria

Christoph Neumayer, J Vasc Endovasc Therapy 2018, Volume 3

DOI: 10.21767/2573-4482-C1-001

Neutrophil extracellular cells have emerged to bemore important

in their role of inflammatory responses than phagocytic actions.

Recent publications showed neutrophils to be involved in the

activation of the IL-1 family and subsequent distribution of

neutrophil proteases to the inflammatory site. The abdominal

aortic aneurysm (AAA) is considered a chronic inflammatory

disease with neutrophils recruited to the aneurysm site and

intraluminal thombus, releasing neutrophil proteases and

reactive oxygen species, which contribute to media destruction.

D-Dimer and myeloperoxidase, distinctive neutrophil proteases

have evolved as potential sensitive AAAmarkers, supporting the

hypothesis of neutrophils to be key players in AAA pathogenesis.

During the recruitment of neutrophils to the aneurysm site and

intraluminal thrombus, activated neutrophils may undergo

the process of NETosis, which involves histone modification

by citrullination, allowing the DNA to be condensated and

subsequent DNA and sticky traps release into the extracellular

space. These NETs are recently discussed to be a potential

biomarker in AAA pathogenesis. NETs were found in AAA

mouse model and its inhibition prevented AAA development.

Furthermore, anti-inflammatory treatment such as metformin

in diabetic patients was associated with reduced AAA growth.

The potential therapeutic approach of metformin in systemic

lupus erythematodous could already be elucidated by reduced

inflammatory skin flares through reduced NET formation.

In summary, neutrophils, neutrophil proteases and NETs are

intensively discussed as potential biomarkers in AAA, this

lecture will give an overview of all recent findings on neutrophils

and their products in AAA.

Recent Publications

1. Piechota-Polanczyk A, Jozkowicz A, Nowak W, Eilenberg

W, Neumayer C, Malinski T, Huk I and Brostjan C (2015):

The abdominal aortic aneurysm and intraluminal

thrombus: current concepts of development and

treatment(review). 2015 Front. Cardiovasc. Med. 2015

Volume 2 Article 19

2. W.Eilenberg,S.Stojkovic,A.Piechota-Polanczyk,C.Kaun,

S. Rauscher, M. Gröger, M. Klinger, J. Wojta, C. Neumayer,

I. Huk, S. Demyanets. Neutrophil Gelatinase-Associated

Lipocalin (NGAL) is associatedwith symptomatic carotid

atherosclerosis and drives pro-inflammatory state in

vitro Eur J Vasc Endovasc Surg (2016) 51(5):623-31

3. W. Eilenberg, S. Stojkovic, A. Kaider, N. Kozakowski,

C.M. Domenig, C. Burghuber, J. Nanobachvili, K. Huber,

C. Neumayer, I. Huk, J. Wojta, S. Demyanets. NGAL and

MMP-9/NGAL as biomarkers of plaque vulnerability and

targets of statins in patients with carotid atherosclerosis.

Clinical Chemistry and LaboratoryMedicine. (2017) June

4. W. Eilenberg, S. Stojkovic, A. Piechota-Polanczyk, A.

Kaider, N. Kozakowski, W. Weninger, J. Nanobachvili, J.

Wojta, I. Huk, S. Demyanets, C. Neumayer. Neutrophil

Gelatinase Associated Lipocalin (NGAL) is elevated in

type 2 diabetics with carotid artery stenosis and reduced

under metformin treatment. Cardiovascular Diabetology

(2017) 16:98

5. Jabłońska A, Neumayer C, Bolliger M, Gollackner B,

Klinger M, Paradowska E, Nanobachvili J, Huk I. Analysis

of host Toll-like receptor 3 and RIG-I-like receptor gene

expression in patients with abdominal aortic aneurysm.

J Vasc Surg. 2018 Mar 19. S0741-5214(17)32687-3.

Biography

Prof. Christoph Neumayer is the interim head of the division of Vascular

Surgery, Department of Surgery, Medical University Vienna. His main re-

search focus inherits carotid atherosclerosis and the abdominal aortic an-

eurysm, especially basic researchmodels of AAA inmice and novel therapy

options.

christoph.neumayer@meduniwien.ac.at